How to relate the observed event to anaphylaxis? Practice of diagnostic investigations;Moyens diagnostiques des réactions immédiates

Annales Francaises d'Anesthesie et de Reanimation

Volumn 30, Issue 3, 2011, Pages 280-293

  Laroche, D ^a   Debaene, B ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b University of Poitiers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLAXIS; ARTICLE; CLINICAL OBSERVATION; CLINICAL PRACTICE; DIAGNOSTIC TEST;

ALLERGENS; ANAPHYLAXIS; ANTIBODY SPECIFICITY; BASOPHIL DEGRANULATION TEST; CELL DEGRANULATION; DRUG HYPERSENSITIVITY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HISTAMINE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; INSECT BITES AND STINGS; INTRAOPERATIVE COMPLICATIONS; LEUKOTRIENES; MAST CELLS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SEROTONIN; TRYPTASES;

EID: 79953143258     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.12.012     Document Type: Article

References (117)

1. Laxenaire MC Épidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999, 18:796-809. Groupe d'études des réactions anaphylactoïdes peranesthésiques.
2. Mertes P.M., Laxenaire M.C., Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003, 99:536-545. Groupe d'études des réactions anaphylactoïdes peranesthésiques.
3. Mertes P.M., Laxenaire MC Épidémiologie des réactions anaphylactiques et anaphylactoïdes peranesthésiques en France. Septième enquête multicentrique (janvier 2001-décembre 2002). Ann Fr Anesth Reanim 2004, 23:1133-1143. les membres du GERAP.
4. Schayer R.W. Catabolism of histamine in vivo. Handb Exp Pharmacol 1966, 18:672-683.
5. Stephan V., Zimmermann A., Kuhr J., Urbanek R. Determination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions. J Allergy Clin Immunol 1990, 86:862-868.
6. Schwartz L.B., Metcalfe D.D., Miller J.S., Earl H., Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987, 316:1622-1626.
7. Castells M.C., Irani A.M., Schwartz L.B. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 1987, 138:2184-2189.
8. Schwartz L.B. Tryptase: a clinical indicator of mast cell-dependent events. Allergy Proc 1994, 15:119-123.
9. Enander I., Matsson P., Nystrand J., Andersson A.S., Eklund E., Bradford T.R., et al. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 1991, 138:39-46.
10. Duff Hogan A., Schwartz L.B. Markers of mast cell degranulation. Methods (San Diego, Calif.) 1997, 13:43-52.
11. Schwartz L.B., Sakai K., Bradford T.R., Ren S., Sweiman B., Worobec A.S., et al. The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995, 96:2702-2710.
12. Granerus G., Lönnqvist B., Nystrand J., Roupe G. Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover. Br J Dermatol 1998, 139:858-861.
13. Payne V., Kam P.C.A. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004, 59:695-703.
14. Laroche D., Vergnaud M.C., Sillard B., Soufarapis H., Bricard H. Biochemical markers of anaphylactoid reactions to drugs. Anesthesiology 1991, 75:945-949.
15. Schwartz L.B., Yunginger J.W., Miller J., Bokhari R., Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989, 83:1551-1555.
16. Van der Linden P.W.G., Hack C.E., Poortman J., Vivié-Kipp Y.C., Struyvenberg A., van der Zwan J.K. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 1992, 90:110-118.
17. Ordoqui E., Zubeldia J.M., Aranzabal A., Rubio M., Herrero T., Tornero P., et al. Serum tryptase levels in adverse drug reactions. Allergy 1997, 52:1102-1105.
18. Bosso J.V., Schwartz L.B., Stevenson D.D. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991, 88:830-837.
19. Ohtsuka T., Matsumaru S., Uchida K., Onobori M., Matsumoto T., Kuwahata K., et al. Time course of plasma histamine and tryptase following food challenges in children with suspected food allergy. Ann Allergy 1993, 71:139-146.
20. Laroche D., Dubois F., Lefrançois C., Vergnaud M.C., Gérard J.L., Soufarapis H., et al. Marqueurs biologiques précoces des réactions anaphylactoïdes peranesthésiques. Ann Fr Anesth Reanim 1992, 11:613-618.
21. Laroche D., Lefrançois C., Gérard J.L., Dubois F., Vergnaud M.C., Guéant J.L., et al. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 1992, 69:611-614.
22. Watkins J. Tryptase release and clinical severity of anaesthetic reactions. Agents Actions 1992; Spec conf issue: C203-05.
23. Fisher M.M., Baldo B.A. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998, 80:26-29.
24. Guéant J.L., Aimone-Gastin I., Laroche D., Pitiot V., Gérard P., Moneret-Vautrin D.A., et al. Prospective evaluation of cell mediator release in anaphylaxis to anesthetic drugs. Allergy Clin Immunol Int 1996, 8:120-122.
25. Cottineau C., Drouet M., Costerousse F., Dussaussoy C., Sabbah A. Intérêt des médiateurs plasmatiques (histamine et tryptase) et urinaires (méthylhistamine) lors de réactions anaphylactiques et/ou anaphylactoïdes peranesthésiques. Allerg Immunol 1996, 28:270-276.
26. Matsson P., Enander I., Andersson A.S., Nystrand J., Schwartz L., Watkins J. Evaluation of mast cell activation (tryptase) in two patients suffering from drug-induced hypotensoid reactions. Agents Actions 1991, 33:218-220.
27. Fernandez J., Blanca M., Moreno F., Garcia J., Segurado E., del Cano A., et al. Role of tryptase, eosinophil cationic protein and histamine in immediate allergic reactions to drugs. Int Arch Allergy Immunol 1995, 107:160-162.
28. Laroche D., Aimone-Gastin I., Dubois F., Huet H., Gérard P., Vergnaud M.C., et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998, 209:183-190.
29. Ring J., Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977, 1:466-468.
30. Ownby D.R., Tomlanovich M., Sammons N., McCullough J. Anaphylaxis associated with latex allergy during barium enema examinations. AJR 1991, 156:903-908.
31. Volcheck G.W., Li J.T.C. Elevated serum tryptase level in a case of intraoperative anaphylaxis caused by latex allergy. Arch Intern Med 1994, 154:2243-2245.
32. Saitoh J., Mitsuhata H., Horiguchi Y., Saitoh K., Fukuda H., Shimizu R. Usefulness of measurement of mast cell tryptase for differential diagnosis of anaphylaxis and anaphylactoid reaction. Masui 1995, 44:1265-1268. (japonais).
33. Mounier P., Laroche D., Divanon F., Mosquet B., Vergnaud M.C., Esse-Comlan A., et al. Réactions anaphylactoïdes à une solution polyvitaminée injectable contenant un crémophore. Therapie 1995, 50:571-573.
34. Takenoshita M., Sugiyama M., Okuno Y., Inagaki Y., Yoshiya I., Shimazaki Y. Anaphylactoid reaction to protamine confirmed by plasma tryptase in a diabetic patient during open heart surgery. Anesthesiology 1996, 84:233-235.
35. Stöckle M., Maachi B., Tunon de Lara M., Roche A., Maurette P. Hypersensibilité au phloroglucinol (Spasfon) dans un contexte d'administration médicamenteuse multiple peranesthésique. Cah Anesthesiol 1997, 45:133-137.
36. Alvarez M.J., Acero S., Mendoza H., Tabar A.L. Cuantification de las concentrationes de triptasa sérica en el diagnostico de anafilaxia. Med Clin (Barc) 1998, 110:357-358.
37. Lopez-Saez M.P., Ordoqui E., Tornero P., Baeza A., Sainza T., Zubeldia J.M., et al. Fluorescein-induced allergic reaction. Ann Allergy Asthma Immunol 1998, 81:428-430.
38. Butrus S.I., Negvesky G.J., Rivera-Velazques P.M., Schwartz L.B. Serum tryptase: an indicator of anaphylaxis following fluorescein angiography. Graefe's Arch Clin Exp Ophtalmol 1999, 237:433-434.
39. Galindo P.A., Borja J., Feo F., Gomez E., Garcia R., Cabrera M., et al. Anaphylaxis to omeprazole. Ann Allergy Asthma Immunol 1999, 82:52-54.
40. Laroche D., Mayo P., Lefrançois C., Dubois F., Vergnaud M.C., Bricard H. Exploration in vitro de l'anaphylaxie médicamenteuse. Immunoanal Biol Spec 1998, 13:63-73.
41. Yunginger J.W., Nelson D.R., Squillace D.L., Jones R.T., Holley K.E., Hyma B.A., et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991, 36:857-865.
42. Edston E., van Hage-Hamsten M. β-tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int 1998, 93:135-142.
43. Petit N., Moneret-Vautrin D.A., Sainte-Laudy J., Kanny G., Vedel G. Dosage post-mortem d'un marqueur biologique d'activation mastocytaire, la tryptase sérique. Étude préliminaire de spécificité. Rev Fr Allergol 1997, 37:827-831.
44. Randall B., Butts J., Halsey J.F. Elevated postmortem tryptase in the absence of anaphylaxis. J Forensic Sci 1995, 40:208-211.
45. Fisher M.M., Baldo B.A. The diagnosis of fatal anaphylactic reactions during anaesthesia: employment of immunoassays for mast cell tryptase and drug-reactive IgE antibodies. Anaesth Intensive Care 1993, 21:353-357.
46. Edston E., Van Hage-Hamsten M., Johansson S.G.O. Tryptase - at last a useful diagnostic marker for anaphylactic death. Allergy 1996, 51:443-445.
47. Schwartz L.B., Bradford T.R., Rouse C., Irani E., Rasp G., van der Zwan J.K., et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994, 14:190-204.
48. Sanchez Palacios A., Ortiz Ponce M., Rodriguez Perez A., Schamann Medina F., Garcia Marrero J.A. Modification of mediators of immune reaction after general anaesthesia. Allergol Immunopathol (Madr) 2004, 32:352-360.
49. Sabbah A., Drouet M., Guittot M. La tryptase: médiateur de la réaction anaphylactique. Étude comparative des dosages fluoro-immuno-enzymométrique (FEIA) et radio-immunologique (RIA). Immunoanal Biol Spec 1998, 13:161-166.
50. Sainte-Laudy J., Cado S. Comparaison des dosages de l'histamine, de la tryptase et de l'interleukine 6 pour l'exploration des réactions anaphylactoïdes médicamenteuses. Allerg Immunol 1998, 30:209-211.
51. Sabbah A., Hassoun S., Drouet M., Lauret M.G., Loiry M., El Founini M., et al. Immuno-biologie allergique et anesthésiologie. Allerg Immunol 1998, 30:173-176.
52. Ryckwaert Y., Barthelet Y., Bonnet-Boyer M.C., Rochette A., Capdevila X., d'Athis F. Choc anaphylactique après dose-test d'aprotinine en chirurgie orthopédique pédiatrique. Ann Fr Anesth Reanim 1999, 18:904-908.
53. Toh K.W., Deacock S.J., Fawcett W.J. Severe anaphylactic reaction to cisatracurium. Anesth Analg 1999, 88:462-464.
54. Seed M.J., Ewan P.W. Anaphylaxis caused by neostigmine. Anaesthesia 2000, 55:574-575.
55. Heier T., Guttormsen A.B. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiol Scand 2000, 44:775-781.
56. Garvey L.H., Roed-Petersen J., Menné T., Husum B. Danish anaesthesia allergy centre- Preliminary results. Acta Anaesthesiol Scand 2001, 45:1204-1209.
57. Dybendal T., Guttormsen A.B., Elsayed S., Askeland B., Harboe T., Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand 2003, 47:1211-1218.
58. Harboe T., Guttormsen A.B., Irgens A., Dybendal T., Florvaag E. Anaphylaxis during anesthesia in Norway. A 6-year single-center follow-up study. Anesthesiology 2005, 102:897-903.
59. Freiler J.F., Steel K.E., Hagan L.L., Rathkopf M.M., Roman-Gonzalez J. Intraoperative anaphylaxis to bacitracin during pacemaker change and laser lead extraction. Annals Allergy Asthma Immunol 2005, 95:389-393.
60. Sandhu S., Farag E., Argalious M. Anaphylaxis to isosulfan blue dye during sentinel lymph node biopsy. J Clin Anesth 2005, 17:633-635.
61. Gooch I., Gwinnutt C. Anaphylaxis to intrathecal diamorphine. Resuscitation 2006, 70:470-473.
62. Hall B.A., Frigas E., Matesic D., Gillett M.D., Sprung J. Case report: intraoperative anaphylactoid reaction and hydroxyethyl starch in balanced electrolyte solution (Hextend®). Can J Anesth 2006, 53:989-993.
63. Brown S.G.A., Blackman K.E., Heddle R.J. Can serum mast cell tryptase help diagnose anaphylaxis?. Emergency Med Australas 2004, 16:120-124.
64. Enrique E., Garcia-Ortega P., Sotorra O., Gaig P., Richart C. Usefulness of UniCAP-tryptase fluoroimmunoassay in the diagnosis of anaphylaxis. Allergy 1999, 54:602-606.
65. Gallimidi E. Dosage de la tryptase totale chez des patients en état de défaillance cardiocirculatoire: anaphylaxie versus non-anaphylaxie. Thèse d'exercice: Médecine: Nancy 1; 2006NAN11071.
66. Konarzewski W., De'Ath S. Unrecognised fatal anaphylactic reaction to propofol or fentanyl. Anaesthesia 2001, 56:485-502.
67. Renz C.L., Laroche D., Thurn J.D., Finn H.A., Lynch J.P., Thisted R., et al. Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 1998, 89:620-625.
68. Nielsen E.W. Hypotensive shock and angio-oedema from angiotensin II receptor blocker: a class effect in spite of tripled tryptase values. J Intern Med 2005, 258:385-387.
69. Donker M.J., van Doormaal J.J., van Doormaal F.F., Kluin P.M., van der Veer E., de Monchy J.G., et al. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis. Haematologica 2008, 93:120-123.
70. Sperr W.R., Jordan J.H., Baghestanian M., Kiener H.P., Samorapoompichit P., Semper H., et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001, 98:2200-2209.
71. Cuculo A., Summaria F., Schiavino D., Liuzzo G., Meo A., Patriarca G., et al. I livelli di triptasi sono elevati durante episodi ischemici spontanei nell'angina instabile ma non dopo test all'ergonovina nell'angina variante. Cardiologia 1998, 43:189-193.
72. Li L., Li Y., Reddel S.W., Cherrian M., Friend D.S., Stevens R.L., et al. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. J Immunol 1998, 161:5079-5086.
73. Lorenz W., Duda D., Dick W., Sitter H., Doenicke A., Black A., et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 1994, 343:933-940.
74. Moss J., Rosow C.E., Savarese J.J., Philbin D.M., Kniffen K.J. Role of histamine in the hypotensive action of d-tubocurarine in humans. Anesthesiology 1981, 55:19-25.
75. Moss J. Muscle relaxants and histamine release. Acta Anesthesiol Scand 1995, 39(supplementatum 106):7-12.
76. Oosting E., Neugebauer E., Keyzer J.J., Lorenz W. Determination of histamine in human plasma: the European external quality control study 1988. Clin Exp Allergy 1990, 20:349-357.
77. Ind P.W., Brown M.J., Lhoste F.J.M., Macquin I., Dollery C.T. Determination of histamine and its metabolites. Concentration-effect relationships of infused histamine in normal volunteers. Agents Actions 1982, 12:12-16.
78. Morel A.M., Delaage M.A. Immunoanalysis of histamine through a novel chemical derivatization. J Allergy Clin Immunol 1988, 82:646-654.
79. McBride P., Bradley D., Kaliner M. Evaluation of a radioimmunoassay for histamine measurement in biologic fluids. J Allergy Clin Immunol 1988, 82:638-646.
80. Halmerbauer G., Hauk P., Forster J., Urbanek R., Kaufmehl K., Koller D.Y. In vivo histamine release during the first minutes after deliberate sting challenges correlates with the severity of allergic symptoms. Pediatr Allergy Immunol 1999, 10:53-57.
81. Laroche D., Dubois F., Gérard J.L., Lefrançois C., André B., Vergnaud M.C., et al. Radioimmunoassay for plasma histamine: a study of false positive and false negative values. Br J Anaesth 1995, 74:430-437.
82. Moss J., Fahmy N.R., Sunder N.S., Beaven M.A. Hormonal and hemodynamic profile of an anaphylactic reaction in man. Circulation 1981, 63:210-213.
83. Cottineau C., Moreau X., Drouet M., De Brux J.L., Brenet O., Delhumeau A. Choc anaphylactique lors de l'utilisation de l'aprotinine à fortes doses en chirurgie cardiaque. Ann Fr Anesth Reanim 1993, 12:590-593.
84. Lorenz W., Neugebauer E., Schmal A. Le dosage de l'histamine plasmatique lors de réactions anaphylactoïdes chez le sujet anesthésié. Ann Fr Anesth Reanim 1982, 1:271-276.
85. Torok E.E., Brewer J.I., Dolkart R.E. Serum diamine oxidase in pregnancy and in trophoblastic diseases. J Clin Endocr Met 1970, 30:59-65.
86. Baylin S.B., Beaven M.A., Krauss R.M., Keiser H.R. Response of plasma histaminase activity to small doses of heparin in normal subjects and patients with hyperlipoproteinemia. J Clin Invest 1973, 52:1985-1993.
87. Laroche D., Gallet E., Bricard H. Histamine sanguine et diagnostic rétrospectif précoce du choc anaphylactique. Ann Fr Anesth Reanim 1988, 7:425-426.
88. Laroche D., Chrysanthou S., Lefrançois C., Gérard J.L., Dubois F., Malet M., et al. Evidence of a progressive degranulation of basophil in subjects operated on without adverse reaction. Agents Actions 1992, 36(special issue):C199-C200.
89. Keyzer J.J., Breukelman H., Wolthers B.G., Richardson F.J., de Monchy J.G.R. Measurement of N-methylhistamine concentrations in plasma and urine as a parameter for histamine release during anaphylactoid reactions. Agents Actions 1985, 16:76-79.
90. Bellia V., Bonanno A., Cibella F., Cuttitta G., Mirabella A., Profita M., et al. Urinary leukotriene E4 in the assessment of nocturnal asthma. J Allergy Clin Immunol 1996, 97:735-741.
91. Yoshida S., Nakagawa H., Yamawaki Y., Sakamoto H., Akahori K., Nakabayashi M., et al. Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma. Int Arch Allergy Immunol 1998, 117:146-151.
92. Sabbah A., Drouet M., El Founini M. Intérêt du dosage des leucotriènes E4 (LTE4) dans les urines. Étude préliminaire. Allerg Immunol 1998, 30:177-178.
93. Oommen A., Grigg J. Urinary leukotriene E4 in preschool children with acute clinical viral wheeze. Eur Respir J 2003, 21:149-154.
94. Misso N.L.A., Aggarwal S., Phelps S., Beard R., Thompson P.J. Urinary leukotriene E4 and 9α, 11β-prostaglandin F2 concentrations in mild, moderate and severe asthma, and in healthy subjects. Clin Exp Allergy 2004, 34:624-631.
95. Oymar K., Aksnes L. Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome. Allergy 2005, 60:86-89.
96. Léturgie P., Lammens S., Lefrançois C., Hanouz J.L., Plaud B., Gérard J.L., et al. Intérêt du dosage des leucotriènes urinaires pour le diagnostic d'évènements allergiques per anesthésiques. Ann Fr Anesth Reanim 2007, 26(Suppl 1):S175.
97. Léturgie P., Plaud B., Gérard J.L., Hanouz J.L., Laroche D. Plasma leukotrienes measurements for diagnosis of anesthetic allergic events. Anesthesiology 2008, 109:A1139.
98. Geuenich S., Haberl C., Egger D., Kaspers U., Hültner L., Wilmanns W., et al. Induction of leukotriene production by bleomycin and asparaginase in mast cells in vitro and in patients in vivo. Biochem Pharmacol 1998, 55:447-453.
99. Takase B., Maruyama T., Kurita A., Uehata A., Nishioka T., Mizuno K., et al. Arachidonic acid metabolites in acute myocardial infarction. Angiology 1996, 47:649-661.
100. Morel D.R., Skoskiewicz M., Robinson D.R., Bloch K.J., Hoaglin D.C., Zapol W.M. Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep. Am J Physiol 1991, 261:H782-H792. [Heart Circ Physiol 30].
101. Lee T.H., Smith C.M., Arm J.P., Christie P.E. Mediator release in aspirin-induced reactions. J Allergy Clin Immunol 1991, 88:827-829.
102. O'Sullivan S., Dahlen B., Dahlen S.E., Kumlin M. Increased urinary excretion of the prostaglandin D2 metabolite 9α,11β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996, 98:421-432.
103. Butterfield J.H., Kao P.C., Klee G.G., Yocum M.W. Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization. Mayo Clin Proc 1995, 70:481-487.
104. Nishio H., Takai S., Miyazaki M., Horiuchi H., Osawa M., Uemura K., et al. Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 2005, 119:331-334.
105. Szczeklik A. Mediator assays in aspirin-induced asthma. Allergy Proc 1994, 15:135-138.
106. Hepner D.L., Castells M.C. Anaphylaxis during the perioperative period. Anesth Analg 2003, 97:1381-1395.
107. Watkins J., Wild G. Improved diagnosis of anaphylactoid reactions by measurements of serum tryptase and urinary methylhistamine. Ann Fr Anesth Reanim 1993, 12:169-172.
108. Fisher M., Baldo B.A. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesth 1994, 11:263-284.
109. Withington D.E. Allergy, anaphylaxis, and anaesthesia. Can J Anaesth 1994, 41:1133-1139.
110. McKinnon R.P., Wildsmith J.A.W. Histaminoid reactions in anaesthesia. Br J Anaesth 1995, 74:217-228.
111. Leynadier F. Choc anaphylactique. Physiopathologie, diagnostic, traitement avec la posologie. Rev Prat 1995, 45:1971-1976.
112. Whittington T., Fisher M.M. Anaphylactic and anaphylactoid reactions. Baillière's Clin Anaesth 1998, 12:301-323.
113. Laxenaire M.C. Choc anaphylactique peranesthésique: conduite à tenir. Ann Fr Anesth Reanim 1997, 16:fi2-fi4.
114. Mertes P.M., Laxenaire M.C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002, 19:240-262.
115. Ebo D.G., Fisher M.M., Hagendorens M.M., Bridts C.H., Stevens W.J. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007, 62:471-487.
116. The diagnosis and management of anaphylaxis. VII. Evaluation and management of patients with a history of anaphylaxis. J Allergy Clin Immunol 1998;101:S482-85.
117. Resuscitation Council. Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. http://www.resus.org.uk/.